First human test of new pain pill halted early
NCT ID NCT06243835
Summary
This was an early-stage study to test the safety and how the body processes a new potential pain medication called Kindolor. It involved healthy adults who received either the drug or a placebo in gradually increasing doses. The main goals were to find a safe dose and understand how the drug moves through the body, but the study was terminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.